RARA and acute promyelocytic leukemia: In consideration of the typical characteristics of ATO in the treatment of APL, we hypothesized that 2.0–4.0 μM Se4+ might induce some interesting changes in APL cells, such as differentiation and the degradation of PML–RARα.